Wedbush Reiterates Outperform Rating on BridgeBio Oncology Therapeutics, In (BBOT)

Go back to Wedbush Reiterates Outperform Rating on BridgeBio Oncology Therapeutics, In (BBOT)
(NASDAQ: BBOT) Delayed: 9.42 +0.22 (2.39%)
Previous Close $9.20    52 Week High
Open $9.07    52 Week Low
Day High $9.46    P/E N/A 
Day Low $9.00    EPS
Volume 150,525